Why the study?
Does the dexamethasone suppression test predict treatment response to antidepressant medication in elderly individuals with major depression?
Does the dexamethasone suppression test predict treatment response to antidepressant medication in elderly individuals with major depression?
The dexamethasone suppression test may help predict treatment response and medication requirements in elderly patients with major depression.
Answers are grounded in this paper and cite their sources.
DST may flag elderly patients needing higher antidepressant doses or facing poorer response; leaves open whether it should guide therapy.
Twenty-seven elderly individuals with DSM-III diagnoses of major depression who demonstrated a nonsuppressor response to the dexamethasone suppression test had higher pretreatment levels of mood disturbance, required higher dosages of antidepressant medication, and had poorer responses to treatment than 17 clinically similar individuals with a suppressor response. However, when data on the outcomes of suppressors and nonsuppressors were combined, over half of the entire group sustained significant improvement, which supports the practical value of DSM-III criteria for depression in the elderly.
No takes yet. Share an insight, caveat, or question.
Spar et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: